Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Sanofi India Limited
SANOFISanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH. Address: Sanofi House, Mumbai, India, 400072
Analytics
Objectif de Cours de WallStreet
684 962.24 INRRatio C/B
26.8099Rendement du dividende
2.72 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés SANOFI
Analyse des dividendes SANOFI
Croissance des dividendes sur 5 ans
430 %Croissance continue
–Ratio de distribution Moyenne sur 5 ans
132 %Historique des dividendes SANOFI
Valorisation des titres SANOFI
financières SANOFI
Résultats | 2019 | Dynamique |